Takeda Pharmaceuticals U.S.A., Inc.
Related Filers (12)
- TAKEDA PHARMACEUTICAL CO LTD (7)
- Takeda Ventures, Inc. (5)
- MILLENNIUM PHARMACEUTICALS INC (5)
- Takeda Pharmaceuticals International AG (3)
- Day One Biopharmaceuticals, Inc. (3)
- Cortexyme, Inc. (2)
- Takeda A/S (1)
- Molecular Templates, Inc. (1)
- Takeda Europe Holdings B.V. (1)
- Takeda Pharma A/S (1)
- Myovant Sciences Ltd. (1)
- Ovid Therapeutics Inc. (1)
- Show More ...
Ownership (8)
4
Wednesday, 7/6/2022
Ovid Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/9/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/7/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/29/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/13/2019
Cortexyme, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/8/2019
Cortexyme, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 3/29/2018
Myovant Sciences Ltd.: Initial statement of beneficial ownership of securities
3
Friday, 9/8/2017
Molecular Templates, Inc.: Initial statement of beneficial ownership of securities